Viking Therapeutics ( (VKTX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viking Therapeutics’ stock is on the rise as analysts maintain a Buy rating, highlighting the company’s strong position in the obesity and metabolic disease market. The mature portfolio and innovative programs, such as VK2735, make Viking an appealing candidate for partnerships. Additionally, its rarity in the late-stage metabolic sector draws investor attention, bolstering its premium valuation.
More about Viking Therapeutics
YTD Price Performance: -38.23%
Average Trading Volume: 6,217,094
Technical Sentiment Signal: Sell
Current Market Cap: $2.86B
For further insights into VKTX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.